DigestRedComo funciona
Red
/
Empresas
EM
No verificado

EMD Serono

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

14 Comunicados de prensa

Ver todos los comunicados de prensa
06/02/2026
Material médico sanitario
Sanidad
Biotecnología
Farmacéutica
Ir de compras
Salud
Telefonía
Industria
EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities
Fuente
EMD Serono
Editor
Business Wire
1.00
0
12/01/2026
Biología
Higiene alimentaria
Sanidad
Salud
Farmacéutica
Oncología
Ciencia
Medicina - Varios
Industria
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
Fuente
EMD Serono
Editor
Business Wire
1.00
0
24/11/2025
Biotecnología
Higiene alimentaria
Sanidad
Salud
Farmacéutica
Ciencia
Medicina - Varios
Industria
EMD Serono Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis
Fuente
EMD Serono
Editor
Business Wire
1.00
0
17/10/2025
Ciencia
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Oncología
Industria
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT
Fuente
EMD Serono
Editor
Business Wire
1.00
0
16/10/2025
Sanidad
Ciencia
Farmacéutica
Política Nacional
Biotecnología
Higiene alimentaria
Salud
Mercado laboral
EMD Serono Announces Unprecedented Agreement with U.S. Government to Expand Access to IVF Therapies
Fuente
EMD Serono
Editor
Business Wire
1.00
0
17/09/2025
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Análisis de Mercados
Industria
EMD Serono to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 2025
Fuente
EMD Serono
Editor
Business Wire
1.00
0
12/06/2025
Biotecnología
Técnica
Salud
Sanidad
Farmacéutica
Tecnología
Ciencia
Medicina - Varios
Eventos
Industria
EMD Serono Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
Fuente
EMD Serono
Editor
Business Wire
1.00
0
28/05/2025
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Farmacéutica
Biotecnología
Eventos
Industria
Pimicotinib Demonstrates Best-in-Class Potential with Significant Efficacy and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumor
Fuente
EMD Serono
Editor
Business Wire
1.00
0
22/05/2025
Eventos
Industria
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Farmacéutica
Biotecnología
EMD Serono Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
Fuente
EMD Serono
Editor
Business Wire
1.00
0
21/05/2025
Industria
Sanidad
Salud
Medicina - Varios
EMD Serono Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active Lupus Rash
Fuente
EMD Serono
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0